We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 18.00 | 31,591 | 07:49:18 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 17.50 | 18.50 | 18.00 | 18.00 | 18.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 14:05:52 | O | 3,868 | 17.768 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/4/2024 | 08:49 | UK RNS | OptiBiotix Health PLC Holding(s) in Company |
| 25/3/2024 | 17:08 | ALNC |  OptiBiotix Health raises GBP1.4 million to invest in "driving sales" |
| 25/3/2024 | 07:00 | UK RNS | OptiBiotix Health PLC Placing, Subscription and Director Dealing |
| 18/3/2024 | 11:36 | UK RNS | SkinBioTherapeutics PLC Holding(s) in Company |
| 13/3/2024 | 20:49 | ALNC | EARNINGS AND TRADING: PensionBee nears profit; OptiBiotix Indian deal |
| 13/3/2024 | 07:00 | UK RNS | OptiBiotix Health PLC Partnership agreement with Morepen for SlimBiome |
| 08/3/2024 | 16:09 | UK RNS | OptiBiotix Health PLC Holding(s) in Company |
| 27/2/2024 | 12:57 | ALNC | OptiBiotix products return to sales growth as pipeline strong |
| 27/2/2024 | 07:00 | UK RNS | OptiBiotix Health PLC Strategic and commercial update |
| 09/2/2024 | 07:00 | UK RNS | OptiBiotix Health PLC Change of auditor |
Optibiotix Health (OPTI) Share Charts1 Year Optibiotix Health Chart |
|
1 Month Optibiotix Health Chart |
Intraday Optibiotix Health Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 19/4/2024 | 12:21 | OptiBiotix - The uncensored thread | 66,093 |
| 15/4/2024 | 19:04 | OptiBiotix Health PLC - | 18,448 |
| 09/10/2023 | 10:42 | OptiBiotix - Better Science, Better Health. Better buy some! | 58,157 |
| 28/6/2023 | 08:01 | OptiBiotix Health (Facts NOT Fiction) | 5,381 |
| 01/2/2021 | 21:24 | SentimentalRules AKA idoflykathy | 77 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 2024-04-19 13:05:53 | 17.77 | 3,868 | 687.27 | O |
| 2024-04-19 12:44:15 | 17.76 | 5,000 | 887.75 | O |
| 2024-04-19 12:11:22 | 18.09 | 1,000 | 180.94 | O |
| 2024-04-19 12:04:07 | 18.09 | 1,000 | 180.94 | O |
| 2024-04-19 11:01:46 | 17.87 | 13,277 | 2,372.87 | O |
| Top Posts |
|---|
Posted at 19/4/2024 09:20 by Optibiotix Health Daily Update Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18p.Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16,414,319. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.34. This morning OPTI shares opened at 18p |
Posted at 12/4/2024 13:19 by vlad the impaler A couple of sucker prices just above 15s but assured price without a BS press release is 15sI think it has to come. Opti still far from finished distributing sbtx , and they need all buyers redirected ro there for that. So the silence shall continue |
Posted at 05/4/2024 13:24 by dudishes Not sure who Tim is talking to, I see no holders around here?Maybe another website (II), including RRR, another toss? I suggest that Tim sells both SBTX and OPTI and plant more dosh into AMRQ where like me, he is a major holder (although one is not clear as to his position, it seems to change from 43p to 46p). I actually think he invested before me (46p), so maybe confusion can be forgiven. I doubled up at 61p, do not believe he did. Seeing no benefit in OPTI/SBTX products, I'll stick with E thankyou. |
Posted at 29/3/2024 13:48 by vlad the impaler Once you had that fad niche sub sector long rally, it's just for traders after that reallySure, it did 20 to 40 , 5s to 40 etc since, but again, at this phase, just for traders Anyone caught 'investing' in these secondary phases post the fad bubble, will be caught badly It's for traders and the inner sanctum only now Each time, it will tank back . There is no medium or long term here, sbtx or PBX anymore It's what is known in some circles as the SP No not share price Sentiment Pincer (post a niche SS rally long past ) |
Posted at 25/3/2024 12:53 by currypasty that's a surpriseOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, cardiovascular disease, diabetes and skincare, announces it has raised in aggregate £1,350,500 through the issue of 6,752,500 new ordinary shares of 2 pence each in the Company ("Fundraise Shares") at a price of 20 pence per share ("Issue Price") (together, the "Fundraise") handled by Peterhouse Capital Limited. |
Posted at 14/3/2024 20:32 by loglorry1 This is all there is to Opti. Its a stock promotion based around getting deals by selling low margin ingredients into bigger product lines.Slimbiome etc is basically two bulking ingredients already in a lot of supplements. OPTI just replace them cheaply to get the deal but it's all low margin. They are a price taker because they have no brand. Stock promotion. |
Posted at 14/3/2024 20:16 by institutional investments Was looking at muscle tech products and I note the pricing is basically the same with leanbiome includedIs that a reflection of opti net margins as per norm? Or are muscle tech happy to reduce their own margins, which would be unusual Either way, the net margin for opti seems to be at a level of brand awareness only I doubt they will be confirming otherwise |
Posted at 13/3/2024 08:42 by loglorry1 This partnership was mentioned in their 27th Feb RNS" Late-stage discussions with a large publicly listed pharmaceutical company in India for a launch of SlimBiome® containing products in India with forecast sales for OptiBiotix in Y1 of £1.2m and Y5 of £6.7m. This is a significant opportunity as the partner is looking to make a substantial investment in marketing to establish SlimBiome® as a major brand in I The revenue is not material. It's just another bogus sales contract. I suspect the conversation goes like this "We'll save you $X by replacing A and B with SlimBiome in your products, SlimBiome is really only A+B and so you can use that instead cheaply, you can use our Brand on t Since OPTI source the A+B ingredients at close to the same rate as any others there is little to no money to be made doing this. |
Posted at 29/2/2024 12:01 by kreature Noses in trough for another 5m converts a Sbtx , and Opti chomping also ? Brilliant really tbfAnyone got the share price dilution calculated after 5m wash out ? |
Posted at 31/10/2023 08:58 by kreature I wouldn’t list a company on AIM unless I had full control over the share price. Must be frustrating not being able to move the share price like a dimmer switch ? |
Posted at 15/8/2023 08:54 by thanatos abyss Vlad The Impaler15 Aug '23 - 08:49 - 64755 of 647580 0 0 Every dope on earth knows the connections between major holders and a board. Never mind one running the other OPTI imo, are dumping sbtx because they obviously know nothing of worth coming, and NOT, selling to mates to rip value again out of opti holders , into private banks .... Interesting. But what if SBTX does come up with another hilarious study so the maker can jump it 300% on one share buy? What should we be thinking about Opti business dealings then ? I'm a bit concerned we are getting ripped off on the opti balance sheet and cash returns as opti holders My concern is mainly due to the ease of which the media and co are saying opti sell rightly for funding I hope it's not a case of justifying selling just prior to mates distributing a much higher sbtx price purchased from opti |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
